Insider Buying Signals: Cogent Biosciences and Generation Bio Show Confidence
Bargain hunters should take note of recent insider trading activity, as it can indicate positive outlooks on stock performance. Insiders often sell stocks for various reasons; however, when they buy, it typically shows they anticipate making money. Today, we highlight two recent insider buys worth your attention.
Cogent Biosciences: A Significant Purchase by CCO Cole Pinnow
Recent SEC filings disclose that on Tuesday, Chief Commercial Officer Cole Pinnow acquired 43,750 shares of Cogent Biosciences (COGT) at $7.60 each, totaling $332,412. Currently, Pinnow is in the positive, enjoying an approximate 11.9% gain based on the latest trading high of $8.50. On Wednesday, Cogent Biosciences saw a market increase of about 13.7%. This marks Pinnow’s first insider buy recorded in the last twelve months.
Generation Bio: Insider Anthony G. Quinn Steps In
At Generation Bio, Anthony G. Quinn made headlines on Monday by purchasing 210,791 shares at a price of $0.96 each, summing up to an investment of $203,209. This purchase marks the first insider transaction filed by Quinn over the past year. Following his buy, Generation Bio is trading approximately 4.3% higher on Wednesday.
VIDEO: Wednesday 1/15 Insider Buying Report: COGT, GBIO
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
